Hernán Valdez
University of North Texas(US)Pfizer (United States)(US)
Publications by Year
Research Areas
HIV Research and Treatment, Dermatology and Skin Diseases, HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, Asthma and respiratory diseases
Most-Cited Works
- → Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial(2020)460 cited
- → Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis(2021)427 cited
- → Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial(2015)390 cited
- → Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis(2020)370 cited
- → Herpes Zoster and Tofacitinib Therapy in Patients With Rheumatoid Arthritis(2014)344 cited
- → Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy(2003)268 cited